Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nonproliferative DR (n=24)

Similar presentations


Presentation on theme: "Nonproliferative DR (n=24)"— Presentation transcript:

1 Nonproliferative DR (n=24)
Table 3. Serum concentrations of PON1 and biochemical parameters in patients with proliferative and nonproliferative retinopathy and with DME Nonproliferative DR (n=24) Proliferative DR (n=24) DR with DME (n=17) DR without DME (n=31) p1 p2 PON1 (U/L) 126 (48-288) 59.5 (27-155) 190 (61-288) 62 (27-137) <0.001† HbA1C (%) 8.5±1.80 8.8±1.68 8.05( ) 8.90( ) 0.550‡ 0.588† Triglycerides (mg/dl) 136 (70-312) 138.5 (56-322) 139±70.5 171.2±72.2 0.787† 0.166‡ Total Cholesterol (mg/dl) 197±26.8 210±47.2 192±28.9 213±45.2 0.983‡ HDL (mg/dl) 47±9.06 46.5±6.4 46.8±9.07 46.5±6.47 0.754‡ LDL (mg/dl) 145 ( ) 155.5 (85-219) 155±42.6 150±30.8 0.879† 0.451‡ NLR 2.59±1.52 2.61 ± 0.80 2.01( ) 2.67( ) 0.421‡ 0.937† Uric acid (mg/dl) 4.8 ( ) 5.5 ( ) 4.9( ) 5.5( ) 0.251† 0.165† Hcy (umol/L) 14.4 ( ) 16.0 ( ) 14.2±3.13 17.4±8.28 0.581† 0.492‡ hsCRP (mg/L) 2.6 ( ) 2.7 ( ) 2.37( ) 3.05( ) 0.606† 0.659† PON:hsCRP ratio 47.9 ( ) 25.8( ) 54 ( ) 21.2 ( ) 0.066† † Mann Whitney U test, ‡ Student’s t test. PON1: Paraoxonase 1 activity DR: Diabetic Retinopathy HDL: High-density lipoprotein LDL: Low-density lipoprotein NLR: Neutrophil-lymphocyte ratio Hcy: Homocysteine, hs-CRP: High-sensitivite CRP DME: Diabetic macular edema p1: Nonproliferative DR vs. Proliferative DR p2: DR with DME vs. DR without DME. Narin NASIROGLU IMGA et al. Low Paraoxonase 1 Activity in Diabetes Mellitus as Predictors of Proliferative Diabetic Retinopathy and Macular Edema. American Journal of Medical Sciences and Medicine, 2016, Vol. 4, No. 4, doi: /ajmsm-4-4-2 © The Author(s) Published by Science and Education Publishing.


Download ppt "Nonproliferative DR (n=24)"

Similar presentations


Ads by Google